Viking Therapeutics Inc (VKTX) Q4 2019 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2019.
Viking Therapeutics
VKTX
VKTX
$5.92
-$0.04
-0.7%
Price as of February 28, 2020, 4:30 p.m. EST
View Interactive VKTX Charts
Viking Therapeutics, Inc.
Interactive Chart
News & Analysis: Viking Therapeutics
The Fool has written over 100 articles on Viking Therapeutics.
Is Viking Therapeutics' Stock a Buy?
Targeting a large and growing disease state, this drug developer's stock requires patience to reap future rewards.
Up 19.2%, Is Viking Therapeutics Stock Still a Buy?
Can the stock march even higher after its recent rally?
Why Viking Therapeutics Stock Soared Today
The biotech's Q3 update fired up investors.
Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics
The biotech rivals each aim to dominate the treatment market for non-alcoholic steatohepatitis (NASH).
3 Top Small-Cap Stocks to Buy in August
These small-cap stocks hold the potential to deliver big-time returns.
Is Viking Therapeutics a Buy?
What you need to know about this high-risk, high-reward biotech stock.
Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2019.
Where Will Viking Therapeutics Be in 1 Year?
It's one of the more promising companies in the race to develop a successful NASH treatment. Will patient investors be rewarded?
3 Stocks to Buy and Hold for the Next 50 Years
The catalysts these companies enjoy could translate into big returns for shareholders in the coming decades.
